Updated July 1 at 9:01am
Health Services
692 results total, viewing 571 - 580
Home Care & Hospice of New England has rebranded itself. Its new name is HopeHealth, effective Monday, March 14. HopeHealth, a nonprofit organization based in Providence, includes includes three affiliated entities: Providence-based Hope Hospice & Palliative Care Rhode Island, Lincoln-based Visiting Nurse of HopeHealth and Hyannis, Mass.-based HopeHealth Massachusetts. more
Dr. Anne S. De Groot is the founder, immune engineer, chief scientific officer and CEO of Providence-based vaccine company EpiVax, which champions the "vaccines-on-demand" movement. She talks with Providence Business News about her experience as a panelist at a health care conference, "The Immunology Revolution: Here Now or Hurry Up and Wait?" more
For all the fuss over tax inversions and the Obama administration’s efforts to prevent them, shares of companies that were able to plow their inversion deals through to the finish line and lock in all those (some would call them nefarious) benefits have to be soaring, right? Not so for Medtronic. more
MedMates, the state’s health care technology network group, has announced that it has hired its first full-time executive director, Kelly Nevins. more
Premama is entering the natural foods market to grow its line of maternity wellness products. more
A $1.5 million renewal grant has been awarded to Women & Infants and Bradley hospitals for their work with the Rhode Island Consortium for Autism Research and Treatment. more
With encouragement from corporate headquarters in Woonsocket, dozens of CVS Health Corp.'s CVS/pharmacy store-setup workers across the country are stubbing out cigarettes, hitting treadmills and choosing water instead of soda for the benefit of … more
Women & Infants Hospital has been designated a “Baby-Friendly” birth facility for its promotion of breastfeeding, making it the second-largest hospital in the country to receive the designation. more
For the second time, Tufts Health Plan recently achieved certification confirming the company’s adherence to the international standards monitored by an industry group for all of its facilities in Massachusetts and Rhode Island. more
With a high-cost cholesterol lowering drug known as a PCSK9 inhibitor newly on the market, CVS Health Research Institute experts are encouraging the cardiology community to reconsider treatment guidelines for the management of high cholesterol. more
« Prev | 1 55 | 56 | 57 | 58 | 59 | 60 | 61 70 | Next »